Implementation and Retrospective Examination of a Lung Cancer Survivorship Clinic in a Comprehensive Cancer Center.

IF 3.3 3区 医学 Q2 ONCOLOGY
Sarah N Price, Alana R Willis, Amy Hensley, Jill Hyson, Stephanie J Sohl, Ralph B D'Agostino, Michael Farris, W Jeffrey Petty, Alberto de Hoyos, Kathryn E Weaver, Stacy Wentworth
{"title":"Implementation and Retrospective Examination of a Lung Cancer Survivorship Clinic in a Comprehensive Cancer Center.","authors":"Sarah N Price, Alana R Willis, Amy Hensley, Jill Hyson, Stephanie J Sohl, Ralph B D'Agostino, Michael Farris, W Jeffrey Petty, Alberto de Hoyos, Kathryn E Weaver, Stacy Wentworth","doi":"10.1016/j.cllc.2024.09.008","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The number of early-stage lung cancer survivors (LCS) is increasing, yet few survivorship programs address their specific needs. We developed a workflow to transition early-stage LCS to dedicated lung survivorship care and comprehensively identify and address their needs using electronic patient-reported outcomes (ePROs).</p><p><strong>Methods: </strong>A lung cancer multidisciplinary team developed a workflow (eg, referrals, survivorship care plan delivery, documentation, orders, tracking, ePROs, and surveillance) for a survivorship clinic staffed by Advanced Practice Providers (APPs). ePROs included the NCCN Distress Thermometer, PROMIS-29, and investigator-developed patient satisfaction items. Patient characteristics, ePROs, and referrals are described; chi-square and t-tests examined ePRO completion by patient characteristics and compared PROMIS-29 domains by treatment modality and to a national sample.</p><p><strong>Results: </strong>From January 2020-March 2023, 315 early-stage LCS completed a survivorship orientation visit. Patient satisfaction was high; 75% completed ePROs. Females were overall less likely to complete ePROs than males; male, age 65+, Black or other race, and rural patients were more likely to complete ePROs in clinic versus online. Patients reported lower symptom burden compared to a general population of early-stage LCS in the United States; scores were similar regardless of treatment modality. Rates of moderate-severe symptoms ranged from 6% (depression) to 42% (poor physical function); ≤ 20% had a referral placed.</p><p><strong>Conclusions: </strong>A referral-based, APP-staffed survivorship clinic model for early-stage LCS which includes ePROs to identify specific needs is acceptable to patients. Future work should include outreach to female LCS and increasing supportive care referrals and acceptability to further address early-stage LCS reported needs.</p>","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cllc.2024.09.008","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The number of early-stage lung cancer survivors (LCS) is increasing, yet few survivorship programs address their specific needs. We developed a workflow to transition early-stage LCS to dedicated lung survivorship care and comprehensively identify and address their needs using electronic patient-reported outcomes (ePROs).

Methods: A lung cancer multidisciplinary team developed a workflow (eg, referrals, survivorship care plan delivery, documentation, orders, tracking, ePROs, and surveillance) for a survivorship clinic staffed by Advanced Practice Providers (APPs). ePROs included the NCCN Distress Thermometer, PROMIS-29, and investigator-developed patient satisfaction items. Patient characteristics, ePROs, and referrals are described; chi-square and t-tests examined ePRO completion by patient characteristics and compared PROMIS-29 domains by treatment modality and to a national sample.

Results: From January 2020-March 2023, 315 early-stage LCS completed a survivorship orientation visit. Patient satisfaction was high; 75% completed ePROs. Females were overall less likely to complete ePROs than males; male, age 65+, Black or other race, and rural patients were more likely to complete ePROs in clinic versus online. Patients reported lower symptom burden compared to a general population of early-stage LCS in the United States; scores were similar regardless of treatment modality. Rates of moderate-severe symptoms ranged from 6% (depression) to 42% (poor physical function); ≤ 20% had a referral placed.

Conclusions: A referral-based, APP-staffed survivorship clinic model for early-stage LCS which includes ePROs to identify specific needs is acceptable to patients. Future work should include outreach to female LCS and increasing supportive care referrals and acceptability to further address early-stage LCS reported needs.

综合癌症中心肺癌幸存者门诊的实施和回顾性检查。
目的:早期肺癌幸存者(LCS)的人数在不断增加,但很少有幸存者计划能满足他们的特殊需求。我们开发了一套工作流程,将早期肺癌幸存者转为专门的肺癌幸存者护理,并利用电子患者报告结果(ePROs)全面识别和满足他们的需求:一个肺癌多学科团队为一个由高级执业医师(APP)组成的幸存者诊所开发了一套工作流程(例如,转诊、幸存者护理计划交付、文档、订单、跟踪、ePROs 和监控)。ePROs 包括 NCCN 痛苦温度计、PROMIS-29 和研究者开发的患者满意度项目。报告对患者特征、ePRO和转诊情况进行了描述;通过卡方检验和t检验按患者特征对ePRO完成情况进行了检查,并按治疗方式和全国样本对PROMIS-29域进行了比较:2020 年 1 月至 2023 年 3 月,315 名早期 LCS 完成了幸存者指导访问。患者满意度很高;75% 的患者完成了 ePRO。总体而言,女性完成 ePRO 的可能性低于男性;男性、65 岁以上、黑人或其他种族以及农村患者在诊所完成 ePRO 的可能性高于在线完成。与美国早期 LCS 患者相比,患者的症状负担较轻;无论采用哪种治疗方式,患者的得分都很接近。中度严重症状率从 6%(抑郁)到 42%(身体功能差)不等;≤ 20% 的患者需要转诊:患者可以接受以转诊为基础、由 APP 人员组成的早期 LCS 幸存者诊所模式,该模式包括 ePRO 以确定特定需求。未来的工作应包括向女性 LCS 开展外展活动,增加支持性护理转诊和接受度,以进一步满足早期 LCS 报告的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical lung cancer
Clinical lung cancer 医学-肿瘤学
CiteScore
7.00
自引率
2.80%
发文量
159
审稿时长
24 days
期刊介绍: Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信